QuidelOrtho Podcast Highlights ADLM 2026 Advances
QuidelOrtho Corporation (NASDAQ: QDEL) released episode 60 of its Science Bytes podcast, detailing advances from the ADLM 2026 conference. The episode discusses innovations in molecular diagnostics and cardiovascular assessments, aiming to provide clinicians with faster, actionable insights.
- QuidelOrtho Corporation (N: ) highlighted advancements in diagnostic technology during their latest podcast, potentially influencing investor sentiment around companies focused on rapid diagnostics and healthcare efficiency. - The discussion around Procalcitonin for antibiotic stewardship suggests potential implications for pharmaceutical and diagnostic companies involved in infection control and antibiotic development.